FibroBiologics (Nasdaq: FBLG) Revenue

Biotechnology Research • Houston, Texas, United States • 11-20 Employees

FibroBiologics (Nasdaq: FBLG) revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	$35,000,000

Key Contact at FibroBiologics (Nasdaq: FBLG)

Pete O'Heeron

Chairman/Ceo/Founder

Company overview

Headquarters	16815 Royal Crest Dr, Suite 100, Houston, Texas 77058, US
Phone number	+12816715150
Website	fibrobiologics.com
NAICS	541714
Employees	11-20
Socials

FibroBiologics (Nasdaq: FBLG) Email Formats

FibroBiologics (Nasdaq: FBLG) uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@fibrobiologics.com), used 61.5% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@fibrobiologics.com	61.5%
{first name}.{last name}	john.doe@fibrobiologics.com	38.5%

About FibroBiologics (Nasdaq: FBLG)

FibroBiologics (Nasdaq: FBLG) is the world leader in cell therapy using fibroblasts to regenerate tissue and cure chronic diseases. Currently, FibroBiologics holds 150+ U.S. and international issued patents issued/pending across a variety of clinical pathways, including Disc Degeneration, Multiple Sclerosis, and Cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Senior

Employees by Department

FibroBiologics (Nasdaq: FBLG) has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore FibroBiologics (Nasdaq: FBLG)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-04-17	18	$5,000,000
2025-01-23	14	$30,000,000

Funding Insights

$35,000,000

Total funding amount

$30,000,000

Most recent funding amount

Number of funding rounds

FibroBiologics (Nasdaq: FBLG) Tech Stack

Discover the technologies and tools that power FibroBiologics (Nasdaq: FBLG)'s digital infrastructure, from frameworks to analytics platforms.

SiteGround

Hosting

Smart Slider 3

WordPress plugins

Vimeo

Video players

DataTables

JavaScript libraries

jQuery UI

JavaScript libraries

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

Frequently asked questions

FibroBiologics (Nasdaq: FBLG) is located in Houston, Texas, US.

You can reach FibroBiologics (Nasdaq: FBLG) at +12816715150.

FibroBiologics (Nasdaq: FBLG) generates an estimated annual revenue of $1,283,325. This revenue figure reflects the company's market position and business performance in its industry.

FibroBiologics (Nasdaq: FBLG) has an estimated valuation of $4,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

FibroBiologics (Nasdaq: FBLG) has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

FibroBiologics (Nasdaq: FBLG) has raised a total of $35,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at FibroBiologics (Nasdaq: FBLG)

Pete O'Heeron

Chairman/Ceo/Founder

4.8

40,000 users